UroGen Pharma Ltd. Quarterly Nonoperating Income (Expense) in USD from Q1 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
UroGen Pharma Ltd. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2022 to Q3 2024.
  • UroGen Pharma Ltd. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$158K, a 323% decline year-over-year.
  • UroGen Pharma Ltd. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $457K.
  • UroGen Pharma Ltd. annual Nonoperating Income (Expense) for 2023 was $838K, a 1064% increase from 2022.
  • UroGen Pharma Ltd. annual Nonoperating Income (Expense) for 2022 was $72K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $457K -$158K -$229K -323% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $686K -$14K +$16K +53.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $670K -$183K -$168K -1120% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $838K $812K Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 $71K +$34K +91.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 -$30K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$15K -$11K -275% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q3 2022 $37K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q1 2022 -$4K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.